CDT Equity Inc. (CDT) vs Niki BioSolutions, Inc. (NIKI)
A side-by-side comparison of CDT Equity Inc. and Niki BioSolutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 3:08 PM EDT
NIKI
Niki BioSolutions, Inc.
$4.69HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT
Total return — CDT vs NIKI
growth of $100 · dividends reinvested · last 3yCDT -100.0% (-99.8%/yr)NIKI -97.6% (-71.0%/yr)NIKI compounded faster over this window
Log scale — wide-divergence pair
CDT NIKI
CDT vs NIKI: by the numbers
- •CDT is the larger company ($678241 vs $381940 market cap).
- •CDT is profitable (6.30% net margin) while NIKI runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CDT | NIKI |
|---|---|---|
| P/S ratio | 0.00 | N/A |
| P/B ratio | 0.00 | 0.02 |
| EV / EBITDA | 4.13 | N/A |
Profitability
| Metric | CDT | NIKI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 6.30% | 0.00% |
| ROE | 6.58% | -5.89% |
| ROIC | 4.47% | -10.38% |
Growth (annualized)
| Metric | CDT | NIKI |
|---|---|---|
| Total return CAGR (5Y) | N/A | -71.40% |
Frequently asked
- Is CDT or NIKI more profitable?
- CDT runs the higher net margin — CDT at 6.30% versus NIKI at 0.00%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.